netFormulary North Central London NHS
Joint Formulary  
 Search
 Results

Looking for Aflibercept found 9 matches

Open monograph to display formulary status BNF Category
  Cytotoxic Drug  Aflibercept  (Zaltrap)
(Oncology)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Restricted Drug  Aflibercept  (Eylea)
(Ophthalmology)
Eye - Subfoveal choroidal neovascularisation - 11.08.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration (11.08.02)
link in drug section NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion (11.08.02)
link in drug section NICE TA307 (not recommended): Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy  (08.01.05)
link in drug section NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy (FOLFIRI) for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy (08.01.05)
link in drug section NICE TA346: Aflibercept for treating diabetic macular oedema (11.08.02)
link in drug section NICE TA409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion (11.08.02)
link in drug section NICE TA486: Aflibercept for treating choroidal neovascularisation (11.08.02)


 

netFormulary